ArticleCirculation2020

Letter by Rozenbaum et al Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".

Mark H Rozenbaum et al.PubMed ↗Publisher ↗

No numbers read from the abstract.